Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.

[1]  M. Betjes.  Immune cell dysfunction and inflammation in end-stage renal disease , 2013, Nature Reviews Nephrology.

[2]  P. Schroder,et al.  Can Immune Cell Function Assay Identify Patients at Risk of Infection or Rejection? A Meta-Analysis , 2012, Transplantation.

[3]  N. Xu,et al.  Invasive fungal infection after liver transplantation: Risk factors and significance of immune cell function monitoring , 2011, Journal of digestive diseases.

[4]  E. Fernández,et al.  Lack of association of immune cell function test with rejection in kidney transplantation. , 2011, Transplantation proceedings.

[5]  C. Agrati,et al.  "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. , 2011, Transplantation proceedings.

[6]  Z. Fu,et al.  The relationship between adenosine triphosphate within CD4+ T lymphocytes and acute rejection after liver transplantation , 2011, Clinical transplantation.

[7]  T. Hamada,et al.  Monitoring peripheral blood CD4+ adenosine triphosphate activity after living donor liver transplantation: impact of combination assays of immune function and CYP3A5 genotype , 2011, Journal of hepato-biliary-pancreatic sciences.

[8]  J. Gralla,et al.  Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[9]  S. Hwang,et al.  Peritransplant monitoring of immune cell function in adult living donor liver transplantation. , 2010, Transplantation proceedings.

[10]  A. Battler,et al.  Individualized Immune Monitoring of Cardiac Transplant Recipients by Noninvasive Longitudinal Cellular Immunity Tests , 2010, Transplantation.

[11]  N. Xu,et al.  Immune Cell Functional Assay in Monitoring of Adult Liver Transplantation Recipients With Infection , 2010, Transplantation.

[12]  G. Serban,et al.  Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy. , 2009, Human immunology.

[13]  D. Pakstis,et al.  Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection , 2009, Transplantation.

[14]  Jen-Jung Pan,et al.  Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  Y. Avitzur,et al.  ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  Valerie B. Sampson,et al.  Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. , 2008, Journal of pediatric surgery.

[17]  M. Arias,et al.  Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection , 2007, Clinical transplantation.

[18]  A. Yussim,et al.  Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform. , 2007, Transplant immunology.

[19]  E. Reed,et al.  Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function Assay , 2006, Transplantation.

[20]  A. Rodriguez-trinidad,et al.  Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. , 2006, Transplantation proceedings.

[21]  Chul-woo Yang,et al.  Clinical Significance of an Early Protocol Biopsy in Living‐Donor Renal Transplantation: Ten‐Year Experience at a Single Center , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  A. Heredia,et al.  Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management , 2003, Clinical transplantation.

[23]  J. Fung,et al.  Quantitation of Immunosuppression by Tacrolimus Using Flow Cytometric Analysis of Interleukin-2 and Interferon-&ggr; Inhibition in CD8− and CD8+ Peripheral Blood T Cells , 2001, Therapeutic drug monitoring.

[24]  J. Soulillou,et al.  Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients , 1997, The Lancet.

[25]  M. Miller,et al.  Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. , 1993, Transplantation.